Sea You at Fetch Long Beach
|Videos|September 13, 2016

Canine lymphoma update

You may have heard it's coming, and now it's here: monoclonal antibody therapy to assist in the treatment of lymphoma in your canine veterinary patients.

Cancer. One word guaranteed to sober any veterinary exam room. But a new weapon of mass destruction just aimed its sights on one of the most common forms of canine cancer, lymphoma, as veterinary oncologist Dr. Sue Ettinger told us at CVC Virginia Beach in May. Used in conjunction with chemotherapy, monoclonal antibody therapy (e.g. Blontress-Aratana) flags cancer cells so the dog's immune system can attack them. Hear more:


Related to this article

Laverdia now available for purchase for dogs with lymphoma
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option that is given twice weekly and showed a longer time to disease progression than control in a field study.
Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
Inside veterinary social work
In a slideshow drawn from an on-site dvm360 interview at the 2026 Fetch National Harbor Veterinary Conference, a veterinary oncologist and a veterinary social worker walk through how the role supports owners and staff across a pet's cancer diagnosis, treatment, and end-of-life care.